May 12, 2021 / 07:30PM GMT
Derik De Bruin - BofA Securities, Research Division - MD of Equity Research
Great. Thank you, operator. Good afternoon, everyone. This is Derik De Bruin, the Senior Life Sciences and Diagnostics Tools Analyst at Bank of America. Welcome to our 2021 virtual Viva Las Vegas Healthcare Conference. My colleague, Mike Ryskin from Bank of America is also here. And our next company up is 10x Genomics. And with us from 10x is CEO, Serge Saxonov; and CFO, Justin McAnear. Gentleman, how are you guys doing?
Serge Saxonov - 10x Genomics, Inc. - Co-Founder, CEO & Director
Great. Thanks for having us.
Justin J. McAnear - 10x Genomics, Inc. - CFO
Thanks, Derik.
Questions and Answers:
Derik De Bruin - BofA Securities, Research Division - MD of Equity ResearchSo 10x was actually -- it's hard to believe that we just did the IPO in late 2019. It feels like -- it feels like a much longer time than we were previously. I could say a lot of the things that we -- a lot of the